Loading...

TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Other Situations 8-K Filing

TV P

TV

TEVA PHARMACEUTICAL INDUSTRIES LTD

(TEVA)

2023 8-K

Credit Agreement Update

Financial Results Update

Financial Statements

Debt Restructuring

Equity Offerings

Financial Statements

Financial Results

Board Appointment

Q3 Financial Results

Financial Results Announcement

Agreement with Israeli Tax ...

Annual Meeting Voting Results

Departure and Appointment o...

Financial Results Announcement

Change in Reporting Segments

Financial Results Announcement

Financial Results Announcement

Collaboration with Sanofi

Departure and Appointment

Entry into a Material Defin...

Appointment of Director

Financial Results Announcement

Annual Meeting Voting Results

Settlement Agreement for Op...

Resignation of Director

Financial Results

External Links:

Teva Pharmaceuticals has entered into a deferred prosecution agreement with the U.S. Department of Justice to settle price-fixing charges, requiring them to pay a $225 million fine over five years and divest one generic product.

AI Assistant

TEVA PHARMACEUTICAL INDUSTRIES LTD

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.